Biolase, Inc. (BIOLQ) vs Nexalin Technology, Inc. (NXL)
- Biolase, Inc. BIOLQ 0.00 NaN
- Nexalin Technology, Inc. NXL 2.35 −4.08%
Biolase, Inc. and Nexalin Technology, Inc. are both Medical Devices companies. Nexalin Technology, Inc. is the larger, with a market value of $2.6M against $2.3M — 1.1× the size. Nexalin Technology, Inc. grew revenue faster over the last twelve months: 24.3% against −7.44%. Biolase, Inc. has the higher net margin (−71.8% vs −4,138.5%) and the higher return on invested capital (−109.5% vs −1,108.8%). Across the 16 metrics below, Biolase, Inc. leads on 12 and Nexalin Technology, Inc. on 4.
Valuation
Profitability
| Metric | BIOLQ | NXL | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | 86.14% | 56.01% |
| Operating margin | (29.37%) | (4,201.66%) | (15.03%) |
| Net margin | (71.75%) | (4,138.49%) | (20.40%) |
| Free cash flow margin | (28.55%) | (2,917.96%) | (7.24%) |
| Return on equity | 1,349.30% | (240.25%) | (15.32%) |
| Return on assets | (100.09%) | (187.89%) | (19.72%) |
| Return on invested capital | (109.48%) | (1,108.82%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack